BridgeMD
New treatment option for Osteoarthritis Finger
Official title Prospective Study of Arthrodesis of Finger Distal Interphalangeal Joints Using the Kerifuse Device
ClinicalTrials.gov ID: NCT06151834
What this study is testing
- What it's testing
- Arthrodesis of a distal interphalangeal joint of the finger (DIP) is mainly performed for a degenerated and painful joint. Various stabilization methods have been used to provide compression at the arthrodesis site such as pins, steel wires, compression screws, headless compression screws, bioresorbable implants and intramedullary staples.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Eligible patients with osteoarthritis of finger for an interphalangeal arthrodesis with KeriFuse implant
You likely can't join if
- Pregnant or breastfeeding patient
- Patient with an intellectual disability and who therefore cannot follow the surgeon's instructions
- Patients with contraindications to surgery
- Patients with acute or chronic, local or systemic infections
- Patients with sensitivities or allergies to device components (Nickel, Titanium)
The study team makes the final eligibility decision.
Where it's taking place
- Nice, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Nice, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.